| Thomas A Dickinson, MD | |
|
1055 N 500 W, Suite 100 Bldg B, Provo, UT 84604-3305 | |
| (801) 374-1268 | |
| (801) 812-5454 |
| Full Name | Thomas A Dickinson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1055 N 500 W, Provo, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376591354 | NPI | - | NPPES |
| 100002620 | Other | UT | PALMETTO GBA |
| 29-00040 | Other | UT | UNITED HEALTHCARE |
| 107006219101 | Other | UT | IHC HEALTHPLANS |
| 0049 | Other | UT | DMBA |
| QM0000009178 | Other | UT | ALTIUS |
| 5285 | Other | UT | PEHP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 1660021205 (Utah) | Primary |
| Entity Name | Central Utah Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.
Longlasting insecticidal nets yielded an important breakthrough in malaria prevention, but this does not automatically mean they always work against diseases transmitted by insect bites. Against the transmission of kala azar disease in India and Nepal they did not have an effect. This was reported by an international group of researchers, led by Marleen Boelaert of the Institute of Tropical Medicine Antwerp, in the reputed British Medical Journal.
Some HIV-positive people in key demographic groups do not seek treatment any sooner than they did in the past, and some people now take longer to initiate treatment, according to a study published in the Nov. 15 issue of Clinical Infectious Diseases, United Press International reports (United Press International, 10/27).
BBI (Europe) Ltd, the pioneer in biometric-sensor based medical devices, launches its ProvizioTM SEM Scanner: the first hand-held, wireless PI/PU risk assessment device with data transfer capabilities.
An 'exhausted' army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas A Dickinson, MD 1055 N 500 W, Credentialing Department, Provo, UT 84604-3305 Ph: (801) 354-8225 | Thomas A Dickinson, MD 1055 N 500 W, Suite 100 Bldg B, Provo, UT 84604-3305 Ph: (801) 374-1268 |
News Archive
In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.
Longlasting insecticidal nets yielded an important breakthrough in malaria prevention, but this does not automatically mean they always work against diseases transmitted by insect bites. Against the transmission of kala azar disease in India and Nepal they did not have an effect. This was reported by an international group of researchers, led by Marleen Boelaert of the Institute of Tropical Medicine Antwerp, in the reputed British Medical Journal.
Some HIV-positive people in key demographic groups do not seek treatment any sooner than they did in the past, and some people now take longer to initiate treatment, according to a study published in the Nov. 15 issue of Clinical Infectious Diseases, United Press International reports (United Press International, 10/27).
BBI (Europe) Ltd, the pioneer in biometric-sensor based medical devices, launches its ProvizioTM SEM Scanner: the first hand-held, wireless PI/PU risk assessment device with data transfer capabilities.
An 'exhausted' army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.
› Verified 4 days ago
Dr. Christopher Gordon, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 745 N 500 W Ste 200, Provo, UT 84601 Phone: 801-375-9292 Fax: 801-375-9290 | |
Daniel N. Bennett, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Ste 101, Building C, Provo, UT 84604 Phone: 801-373-4366 | |
Dr. Christopher Ryan Lew, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-960-7558 | |
Albert Rivero, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1134 N 500 W Ste 101, Provo, UT 84604 Phone: 801-357-8310 | |
Dr. Wenshu Yu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3650 N University Ave Ste 150, Provo, UT 84604 Phone: 801-818-1940 Fax: 801-818-1945 | |
William T. Stephenson Ii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 103, Provo, UT 84604 Phone: 801-357-8200 Fax: 801-357-8201 | |
Gregory E Craner, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1055 N 500 W, Suite 100 Bldg B, Provo, UT 84604 Phone: 801-374-1268 Fax: 801-429-8041 |